We are live on ! Find out more
SCM

Sarissa Capital Management Portfolio holdings

AUM $158M
1-Year Est. Return 103.7%
This Fund
S&P 500
This Quarter Est. Return
+12.16%
1 Year Est. Return
+103.7%
3 Year Est. Return
+58.62%
5 Year Est. Return
+92.85%
10 Year Est. Return
+667.68%
AUM
$453M
AUM Growth
-$45.5M
Cap. Flow
-$93.8M
Cap. Flow %
-20.7%
Top 10 Hldgs %
100%
Holding
10
New
–
Increased
–
Reduced
2
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
SHPG
Shire pic
SHPG
+$53.3M
2
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
+$40M
3
SEEL
Seelos Therapeutics, Inc. Common Stock
SEEL
+$564K

Sector Composition

Rank Sector Weight
1 Healthcare 87.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BIIB icon
1
Biogen
BIIB
$30B
$163M 36%
461,858
– –
INVA icon
2
Innoviva
INVA
$1.55B
$69.1M 15.25%
4,535,000
– –
AGN
3
DELISTED
Allergan plc
AGN
$65.5M 14.45%
344,000
– –
IRWD icon
4
Ironwood Pharmaceuticals
IRWD
$696M
$62.2M 13.71%
4,020,317
– –
MDCO
5
DELISTED
Medicines Co
MDCO
$57.5M 12.68%
1,922,000
– –
ICPT
6
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$32.5M 7.18%
257,500
-377,800
-59% -$40M
NVLN
7
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
$3.03M 0.67%
1,025,000
– –
SHPG
8
DELISTED
Shire pic
SHPG
$181K 0.04%
1,000
-308,000
-100% -$53.3M
ABBV icon
9
AbbVie
ABBV
$443B
$94K 0.02%
1,000
– –
SEEL
10
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
– –
-13
Closed -$564K

Similar funds

4A
4D Advisors Redondo Beach, California $158M AUM 92.73% 1-Year Est. Return
DAM
Deepwater Asset Management Minneapolis, Minnesota $158M AUM 23.9% 1-Year Est. Return
PCP
Pantera Capital Partners San Francisco, California $158M AUM 600.89% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $157M AUM
HEM
Henson-Edgewater Management Avon, Ohio $157M AUM
SF
Seros Financial Tempe, Arizona $157M AUM 16.95% 1-Year Est. Return
AC
AlpenGlobal Capital Tahoe City, California $157M AUM
EP
Elkhorn Partners Omaha, Nebraska $157M AUM 11.91% 1-Year Est. Return

Sarissa Capital Management's Q3 2018 Portfolio in Review

As of Q3 2018, Sarissa Capital Management held 10 positions worth $453M, down 9.1% from $499M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Sarissa Capital Management withdrew a net $93.8M in Q3 2018, closing 1 position and reducing 2 holdings. Its most notable exit was Seelos Therapeutics, Inc. Common Stock, an estimated $564K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 87% of assets, up from 86% a quarter earlier.

  • Sarissa Capital Management's biggest Q3 2018 reduction was Shire pic, cutting an estimated $53.3M.
  • Sarissa Capital Management fully exited Seelos Therapeutics, Inc. Common Stock in Q3 2018, selling an estimated $564K.
  • Sarissa Capital Management's ten largest holdings make up 100% of its $453M portfolio in Q3 2018.
  • Sarissa Capital Management opened 0 new positions and closed 1 in Q3 2018.
  • Sarissa Capital Management's portfolio value fell 9.1% quarter-over-quarter to $453M.

Based on Sarissa Capital Management's 13F filing for Q3 2018, filed 14 Nov 2018.